Human medicines European public assessment report (EPAR): Calquence, acalabrutinib, Date of authorisation: 05/11/2020, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Ordspono, odronextamab, Date of authorisation: 22/08/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Trixeo Aerosphere, formoterol,glycopyrronium bromide,budesonide, Date of authorisation: 09/12/2020, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Tepkinly, epcoritamab, Date of authorisation: 22/09/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Ervebo, Ebola Zaire vaccine (rVSV∆G-ZEBOV-GP, live), Date of authorisation: 11/11/2019, Revision: 11, Status: Authorised

Referral: Ixchiq, Chikungunya vaccine (live) Article 20 procedures European Commission final decision, 24/07/2025, 12/09/2025, 19/09/2025

EVVet3 EVWeb Production - Release notes

Human medicines European public assessment report (EPAR): Enflonsia, clesrovimab, Status: Opinion

Human medicines European public assessment report (EPAR): Imaavy, nipocalimab, Status: Opinion

First treatment recommended for rare immunoglobulin-related autoimmune disease